东宝生物：积极推进回购股份计划

Core Viewpoint - Dongbao Biological is actively promoting its share repurchase plan to enhance employee incentive mechanisms and support its strategic goals in the collagen industry [1][2] Group 1: Share Repurchase Plan - The company approved a share repurchase plan on January 3, intending to use its own and/or raised funds to buy back its A-shares through centralized bidding or other legal methods [1] - The repurchase amount is set between RMB 50 million and RMB 100 million, with a maximum repurchase price of RMB 8.00 per share [1] - As of March 31, the company has repurchased 7.348 million shares, accounting for 1.2379% of the total share capital, with a total transaction amount of RMB 40.1431 million [1] Group 2: Strategic Focus and Goals - Dongbao Biological focuses on the collagen industry, aiming to innovate and deepen the application of collagen across medical, health, food, and beauty sectors [1] - The company plans to create a vertically integrated product strategy, enhancing brand and channel collaboration to diversify and increase revenue [2] - The goal is to become a leading brand in the domestic collagen market and a comprehensive enterprise group in the health industry, emphasizing scale, platform, and brand benefits [2]